These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 20589670

  • 41. Production of high-titer human influenza A virus with adherent and suspension MDCK cells cultured in a single-use hollow fiber bioreactor.
    Tapia F, Vogel T, Genzel Y, Behrendt I, Hirschel M, Gangemi JD, Reichl U.
    Vaccine; 2014 Feb 12; 32(8):1003-11. PubMed ID: 24269322
    [Abstract] [Full Text] [Related]

  • 42. Genetic engineering of live attenuated influenza viruses.
    Jin H, Chen Z, Liu J, Kemble G.
    Methods Mol Biol; 2012 Feb 12; 865():163-74. PubMed ID: 22528159
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. MDCK cell-cultured influenza virus vaccine protects mice from lethal challenge with different influenza viruses.
    Liu K, Yao Z, Zhang L, Li J, Xing L, Wang X.
    Appl Microbiol Biotechnol; 2012 Jun 12; 94(5):1173-9. PubMed ID: 22415544
    [Abstract] [Full Text] [Related]

  • 49. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA.
    Pediatrics; 2006 Sep 12; 118(3):e570-8. PubMed ID: 16950948
    [Abstract] [Full Text] [Related]

  • 50. Mathematical model of influenza A virus production in large-scale microcarrier culture.
    Möhler L, Flockerzi D, Sann H, Reichl U.
    Biotechnol Bioeng; 2005 Apr 05; 90(1):46-58. PubMed ID: 15736163
    [Abstract] [Full Text] [Related]

  • 51. Development of cell culture (MDCK) live cold-adapted (CA) attenuated influenza vaccine.
    Ghendon YZ, Markushin SG, Akopova II, Koptiaeva IB, Nechaeva EA, Mazurkova LA, Radaeva IF, Kolokoltseva TD.
    Vaccine; 2005 Sep 07; 23(38):4678-84. PubMed ID: 16026905
    [Abstract] [Full Text] [Related]

  • 52. High titer growth of human and avian influenza viruses in an immortalized chick embryo cell line without the need for exogenous proteases.
    Smith KA, Colvin CJ, Weber PS, Spatz SJ, Coussens PM.
    Vaccine; 2008 Jul 04; 26(29-30):3778-82. PubMed ID: 18524432
    [Abstract] [Full Text] [Related]

  • 53. Establishment of a mink enteritis vaccine production process in stirred-tank reactor and Wave Bioreactor microcarrier culture in 1-10 L scale.
    Hundt B, Best C, Schlawin N, Kassner H, Genzel Y, Reichl U.
    Vaccine; 2007 May 16; 25(20):3987-95. PubMed ID: 17391818
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Rapid production of a H₉ N₂ influenza vaccine from MDCK cells for protecting chicken against influenza virus infection.
    Ren Z, Lu Z, Wang L, Huo Z, Cui J, Zheng T, Dai Q, Chen C, Qin M, Chen M, Yang R.
    Appl Microbiol Biotechnol; 2015 Apr 16; 99(7):2999-3013. PubMed ID: 25646963
    [Abstract] [Full Text] [Related]

  • 56. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
    Fleming DM, Crovari P, Wahn U, Klemola T, Schlesinger Y, Langussis A, Øymar K, Garcia ML, Krygier A, Costa H, Heininger U, Pregaldien JL, Cheng SM, Skinner J, Razmpour A, Saville M, Gruber WC, Forrest B, CAIV-T Asthma Study Group.
    Pediatr Infect Dis J; 2006 Oct 16; 25(10):860-9. PubMed ID: 17006278
    [Abstract] [Full Text] [Related]

  • 57. Immortalized chick embryo cell line adapted to serum-free growth conditions and capable of replicating human and reassortant H5N1 influenza strains for vaccine production.
    Coussens PM, Smith KA, Weber PS, Colvin CJ.
    Vaccine; 2011 Nov 03; 29(47):8661-8. PubMed ID: 21911025
    [Abstract] [Full Text] [Related]

  • 58. Comparison of immunogenicity of cell-and egg-passaged viruses for manufacturing MDCK cell culture-based influenza vaccines.
    Shin D, Park KJ, Lee H, Cho EY, Kim MS, Hwang MH, Kim SI, Ahn DH.
    Virus Res; 2015 Jun 02; 204():40-6. PubMed ID: 25892718
    [Abstract] [Full Text] [Related]

  • 59. [Adherent and single-cell suspension culture of Madin-Darby canine kidney cells in serum-free medium].
    Huang D, Zhao L, Tan W.
    Sheng Wu Gong Cheng Xue Bao; 2011 Apr 02; 27(4):645-52. PubMed ID: 21848001
    [Abstract] [Full Text] [Related]

  • 60. Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production.
    Montomoli E, Khadang B, Piccirella S, Trombetta C, Mennitto E, Manini I, Stanzani V, Lapini G.
    Expert Rev Vaccines; 2012 May 02; 11(5):587-94. PubMed ID: 22827244
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.